MedPath

Evaluation of the sequence of traditional Chinese medicine based on the practicality of the real world Clinical efficacy of treatment of Rheumatoid Arthritis

Not Applicable
Not yet recruiting
Conditions
Rheumatoid Arthritis
Registration Number
ITMCTR2100005077
Lead Sponsor
ZHEJIANG CHINESE MEDICAL UNIVERSITY
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the 2010 ACR/EULAR RA classification standard;
2. 5.1>DAS28>3.2 (at the time of enrollment, the RA patients were in active condition);
3. RA patients with syndrome of spleen deficiency and dampness toxin stasis obstruction;
4. Course of disease <= 24 months;
5. Aged 18 to 65 years;
6. The patient informed and agreed to participate in this study.

Exclusion Criteria

1. Patients with severe organ disease or mental illness;
2. Those who are allergic to the drugs involved in the research protocol or have contraindications to their use.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.